From Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials:

Nancy Simonian, CEO of Syros Pharmaceuticals
Nancy Simonian, CEO of Syros Pharmaceuticals

Nancy Simonian, CEO of Syros Pharmaceuticals